OSPREY THERAPEUTICS
Ionis Pharmaceuticals, Inc.
Application Filed: 2017-12-18
Trademark Application Details
FIRST EXTENSION - GRANTED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87725262 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Karen K. Won |
| Attorney Docket Number | 097721-20084 |
| Law Office Assigned | M60 |
| Employee Name | YARD, JOHN S |
Timeline
| 2017-12-18 | Application Filed |
| 2018-05-15 | Published for Opposition |
| 2018-07-10 | Location: INTENT TO USE SECTION |
| 2019-01-04 | Status: Live/Pending |
| 2019-01-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Ionis Pharmaceuticals, Inc. |
| Address | 2855 Gazelle Court Carlsbad DE 92010 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases and disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and disorders; pharmaceutical preparations for the prevention and treatment of endocrinological diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases or disorders; pharmaceutical preparations for the prevention and treatment of liver diseases or disorders pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in gynecology and urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of genetic diseases and disorders |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-12-21 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-01-04 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2018-03-27 | 3 DOCK D:Assigned to Examiner |
| EXAMINERS AMENDMENT -WRITTEN | 2018-03-30 | 4 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2018-03-30 | 5 GNEA F:First Action |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2018-03-30 | 6 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2018-03-30 | 7 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2018-03-30 | 8 CNSA P: |
| ASSIGNED TO LIE | 2018-04-04 | 9 ALIE A:Allowance for Publication |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2018-04-25 | 10 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2018-05-15 | 11 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2018-05-15 | 12 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2018-07-10 | 13 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-01-04 | 14 EEXT I:Incoming Correspondence |
| EXTENSION 1 FILED | 2019-01-04 | 15 EXT1 S: |
| EXTENSION 1 GRANTED | 2019-01-04 | 16 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-01-08 | 17 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2019-07-08 | 18 EEXT I:Incoming Correspondence |
| EXTENSION 2 FILED | 2019-07-08 | 19 EXT2 S: |
| EXTENSION 2 GRANTED | 2019-07-08 | 20 EX2G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-07-10 | 21 EXRA E:E-Mail |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2019-10-11 | 22 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2019-10-11 | 23 ARAA I:Incoming Correspondence |
| TEAS EXTENSION RECEIVED | 2020-01-03 | 24 EEXT I:Incoming Correspondence |
| EXTENSION 3 FILED | 2020-01-03 | 25 EXT3 S: |
| EXTENSION 3 GRANTED | 2020-01-03 | 26 EX3G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-01-07 | 27 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-06-30 | 28 EEXT I:Incoming Correspondence |
| EXTENSION 4 FILED | 2020-06-30 | 29 EXT4 S: |
| EXTENSION 4 GRANTED | 2020-06-30 | 30 EX4G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-07-02 | 31 EXRA E:E-Mail |
| TEAS EXTENSION RECEIVED | 2020-12-11 | 32 EEXT I:Incoming Correspondence |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2020-12-30 | 33 AITU A:Allowance for Publication |
| EXTENSION 5 FILED | 2020-12-11 | 34 EXT5 S: |
| EXTENSION 5 GRANTED | 2020-12-30 | 35 EX5G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-12-31 | 36 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2021-08-16 | 37 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2021-08-16 | 38 MAB6 E:E-Mail |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OSPREY THERAPEUTICS 87725262 not registered Live/Pending |
Ionis Pharmaceuticals, Inc. 2017-12-18 |
 OSPREY THERAPEUTICS 87725257 not registered Live/Pending |
Ionis Pharmaceuticals, Inc. 2017-12-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 